Webinar

Catch up on our webinar exploring how gene expression testing could advance care for premenopausal breast cancer patients. Experts PD Dr. med. Evelyn Klein and Prof. Michalis Kontos, PhD shared insights on therapy selection, guidelines and validation data for premenopausal patients.

This session takes a patient-centric look at how clinical, pathological, and genomic markers come together to inform long-term risk in ER+/HER2- breast cancer. Dr. Jessica Leitsmann explored what really matters in day-to-day practice — especially beyond the critical 5-year mark  and how prognostic tools can support truly individualized treatment strategies.